CD8A and neoplasm: We demonstrated that MDSCs express perforin and GzmB, and that these effector molecules contribute to the MDSCs ability to promote tumor progression in multiple ways, namely enhanced invasive capability of tumor cells, enhanced tumor growth, and the ability to influence CD8+ T-cell responses.